Association of Northern California Oncologists

http://www.anco.org/

 

2019 ANCO's ASCO Highlights in Metastatic Bladder Cancer: Should We Add Bevacizumab to Chemo, Is There a Role of Maintenance IO After Chemo, & New Data on Enfortumab Vedotin

233 views
September 6, 2019
0 Comments
Login to view comments. Click here to Login